Arpida Alternatives & Competitors
12 companies similar to Arpida
Companies similar to Arpida
Arrevus
Conquering antibiotic resistance by targeting critical diseases with innovative DPCs.
Microbion Corporation
Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic,...
Allecra Therapeutics
Our Mission: Answering the call to action to fight antibiotic resistance
Rival Readout
Competing with Arpida? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ASLAN Pharmaceuticals
A clinical-stage immunology focused biopharmaceutical company.
Venatorx Pharmaceuticals, Inc.
Discovering & developing novel anti-infectives to treat multi-drug resistant bacterial & h...
Prokaryotics, Inc.
Antibacterial discovery organization committed to bringing forth innovative therapeutics t...
ORIC Pharmaceuticals Inc.
Overcoming Resistance In Cancer
Convalife Pharmaceuticals
Pioneering the future of tumor disease treatment through advanced pharmaceutical research...
PolyPid Ltd.
Controlled, extended-release, local delivery of medication at effective release rates over...
Alzprotect SAS
Therapeutic Solutions for Neurodegeneration
EGeen International Corporation
A Full Service CRO for Rapid, Cost-Effective Clinical Trial Execution
About Arpida
Arpida is a biopharmaceutical company (SIX: ARPN) headquartered in Reinach, near Basel, Switzerland with operations in Switzerland and the USA. Established in 1997, the company focuses on novel drugs that address the growing issue of microbial resistance. Arpida’s primary product candidate is intravenous iclaprim, an a...
Biopharmaceutical, Antibiotic, MRSA, Drug Development, Microbial Resistance, Infections, IV Iclaprim, Medical Research, Pharmaceutical Industry, Clinical Trials, Switzerland, USA, Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Arpida: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Arpida on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.